Colt Egelston

12PUBLICATIONS
49CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 20, 2026
Baseline Tumor Features and Systemic Immune Dynamics Underlying Efficacy in MSS Metastatic Colorectal Cancer Treated with Regorafenib, Ipilimumab, and Nivolumab.

Jian Ye, Chongkai Wang, Colt A Egelston

|Dec 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales

|Oct 04, 2024
Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.

Weihua Guo, Jiayi Tan, Lei Wang

|Jul 25, 2024
Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer.

Colt A Egelston, Weihua Guo, Diana L Simons

|Sep 28, 2023
Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases.

Jian Ye, Weihua Guo, Chongkai Wang

|Jun 20, 2023
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.

Matthew Mei, Lu Chen, James Godfrey

Pageof 2

Frequent Collaborators

5 joint publications

Peter P Lee

5 joint publications

Weihua Guo

3 joint publications

Jian Ye

2 joint publications

Christian Avalos